NAS:SGRY (USA) Also trade in: Germany

Surgery Partners Inc

$ 7.5 0 (0%)
Volume: 330,566 Avg Vol (1m): 373,299
Market Cap $: 373.04 Mil Enterprise Value $: 3.37 Bil
P/E (TTM): 0.00 P/B: 0.97
Earnings Power Value -25.49
Net Current Asset Value -82.3
Tangible Book -63.6
Projected FCF 0
Median P/S Value 28.39
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 3.9/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.06
Cash-To-Debt range over the past 10 years
Min: 0.03, Med: 0.04, Max: 0.1
Current: 0.06
0.03
0.1
Equity-to-Asset 0.08
Equity-to-Asset range over the past 10 years
Min: -0.15, Med: 0, Max: 0.14
Current: 0.08
-0.15
0.14
Debt-to-Equity 6.24
Debt-to-Equity range over the past 10 years
Min: -311.66, Med: 3.41, Max: 291.94
Current: 6.24
-311.66
291.94
Debt-to-EBITDA 7.47
Debt-to-EBITDA range over the past 10 years
Min: 5.2, Med: 6.1, Max: 12.21
Current: 7.47
5.2
12.21
Interest Coverage 1.66
Interest Coverage range over the past 10 years
Min: 1.55, Med: 1.87, Max: 2.15
Current: 1.66
1.55
2.15
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.46
DISTRESS
GREY
SAFE
Beneish M-Score -1.88
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 10.23%
WACC 9%

Profitability & Growth : 6/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 14.47
Operating Margin range over the past 10 years
Min: 14.27, Med: 21.09, Max: 24.8
Current: 14.47
14.27
24.8
Net Margin % -11.76
Net Margin range over the past 10 years
Min: -16.34, Med: -1.52, Max: 0.83
Current: -11.76
-16.34
0.83
ROE % -46.51
ROE range over the past 10 years
Min: -46.51, Med: 144.86, Max: 334.68
Current: -46.51
-46.51
334.68
ROA % -4.47
ROA range over the past 10 years
Min: -5.65, Med: -3.82, Max: 0.43
Current: -4.47
-5.65
0.43
ROC (Joel Greenblatt) % 47.83
ROC (Joel Greenblatt) range over the past 10 years
Min: 46.85, Med: 65.99, Max: 253.83
Current: 47.83
46.85
253.83
3-Year Total Revenue Growth Rate 22.70
3-Year Revenue Growth Rate range over the past 10 years
Min: -100, Med: 35.95, Max: 68
Current: 12.9
-100
68
3-Year Total EBITDA Growth Rate 14.50
3-Year EBITDA Growth Rate range over the past 10 years
Min: -100, Med: 23.75, Max: 55.8
Current: 5.4
-100
55.8

» SGRY's 30-Y Financials

Financials (Next Earnings Date: 2019-08-09)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:SGRY

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Health Care Providers    NAICS : 621493    SIC : 8099
Compare XSGO:LAS CONDES SGX:5G3 NSE:NH SAU:4005 XSGO:INDISA ISX:SILO CAI:CLHO.CA LSE:CTH HKSE:03309 TSE:6099 IST:MPARK BKK:CHG NYSE:CYH LSE:SPI HKSE:02120 HKSE:02138 TSX:DR NAS:AMEH ISX:HEAL LSE:MDMG
Traded in other countries 1SP.Germany
Address 310 Seven Springs Way, Suite 500, Brentwood, TN, USA, 37027
Surgery Partners Inc is a healthcare service company. It owns and operates ambulatory surgery centers providing services including anesthesia, diagnostic testing and radiation oncology.

Ratios

Current vs industry vs history
PB Ratio 0.97
PB Ratio range over the past 10 years
Min: 0.56, Med: 1.33, Max: 177.73
Current: 0.97
0.56
177.73
PS Ratio 0.21
PS Ratio range over the past 10 years
Min: 0.21, Med: 0.77, Max: 1.36
Current: 0.21
0.21
1.36
Price-to-Free-Cash-Flow 3.84
Price-to-Free-Cash-Flow range over the past 10 years
Min: 3.84, Med: 10.43, Max: 28.29
Current: 3.84
3.84
28.29
Price-to-Operating-Cash-Flow 2.73
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 2.73, Med: 7.03, Max: 18.02
Current: 2.73
2.73
18.02
EV-to-EBIT 13.12
EV-to-EBIT range over the past 10 years
Min: 11.8, Med: 14.1, Max: 47.1
Current: 13.12
11.8
47.1
EV-to-EBITDA 10.31
EV-to-EBITDA range over the past 10 years
Min: 9.8, Med: 11.4, Max: 35.2
Current: 10.31
9.8
35.2
EV-to-Revenue 1.92
EV-to-Revenue range over the past 10 years
Min: 1.9, Med: 2.4, Max: 6.3
Current: 1.92
1.9
6.3
Current Ratio 1.49
Current Ratio range over the past 10 years
Min: 1.49, Med: 1.76, Max: 2.15
Current: 1.49
1.49
2.15
Quick Ratio 1.37
Quick Ratio range over the past 10 years
Min: 1.37, Med: 1.62, Max: 2
Current: 1.37
1.37
2
Days Inventory 12.09
Days Inventory range over the past 10 years
Min: 4.91, Med: 12.08, Max: 20.29
Current: 12.09
4.91
20.29
Days Sales Outstanding 60.78
Days Sales Outstanding range over the past 10 years
Min: 60.78, Med: 69.79, Max: 131.2
Current: 60.78
60.78
131.2
Days Payable 18.70
Days Payable range over the past 10 years
Min: 18.7, Med: 24.73, Max: 61.84
Current: 18.7
18.7
61.84

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate 0.10
3-Year Share Buyback Rate range over the past 10 years
Min: -0.4, Med: -0.1, Max: 0.1
Current: 0.1
-0.4
0.1

Valuation & Return

Current vs industry vs history
Price-to-Median-PS-Value 0.26
Price-to-Median-PS-Value range over the past 10 years
Min: 0.26, Med: 1.06, Max: 1.53
Current: 0.26
0.26
1.53
Earnings Yield (Joel Greenblatt) % 7.51
Earnings Yield (Greenblatt) range over the past 10 years
Min: 2.1, Med: 7.1, Max: 8.5
Current: 7.51
2.1
8.5

More Statistics

Revenue (TTM) (Mil) $ 1,770.89
EPS (TTM) $ -5.03
Beta 2.58
Volatility % 58.79
52-Week Range $ 7.48 - 18.7
Shares Outstanding (Mil) 48.87

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA N
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y